SynGenis
PrivateLast Round
Growth Equity
Jul 12, 2026
Total Funding Raised
$2.78M
Company Overview
SynGenis is a biotechnology company that specializes in the production and supply of high-quality oligonucleotides for diagnostic and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynGenis Comparables
Compare SynGenis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synoligo Biotechnologies | 83% | |
| Messenger Bio | 74% | |
| Danaher | 72% |
SynGenis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 12, 2026 | ||||
| Seed | Mar 1, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
Grew 63% QoQ, from 8 to 13 employees.
- Apr 11, 2026
Grew 71% QoQ, from 7 to 12 employees.
Recent news
Latest coverage and updates
- is_developingAug 24, 2026
SynGenis Pty Ltd is developing artificial intelligence engine.
- receives_financingAug 24, 2026
SynGenis Pty Ltd received financing of $363K on Aug 25th '26.
- invests_into_assetsAug 24, 2026
SynGenis Pty Ltd will invest into assets: Good Manufacturing Practice (GMP) facility in Australia, Australia and New Zealand, Oceania on Jan 1st '27.
- receives_financingJul 13, 2026
SynGenis Pty Ltd received financing of $4M in pre-IPO on Jul 13th '26.
SynGenis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SynGenis's valuation, stock price, and market status.
Is SynGenis a public or private company?
SynGenis is a private company.
What is the current stock price of SynGenis?
SynGenis is a private company with no public stock price. No recent secondary market data is available.
How much is SynGenis worth (valuation)?
Valuation information for SynGenis is not publicly available.
Can I buy SynGenis stock?
SynGenis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SynGenis's last funding round?
SynGenis's most recent funding round was Growth Equity on July 12, 2026.
Who are the main investors in SynGenis?
Investor information for SynGenis is not publicly disclosed.
Will SynGenis IPO soon?
No public IPO plans have been announced for SynGenis.
How can I track SynGenis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SynGenis's secondary market activity and sign up for updates.